CH672887A5 - - Google Patents

Download PDF

Info

Publication number
CH672887A5
CH672887A5 CH4022/87A CH402287A CH672887A5 CH 672887 A5 CH672887 A5 CH 672887A5 CH 4022/87 A CH4022/87 A CH 4022/87A CH 402287 A CH402287 A CH 402287A CH 672887 A5 CH672887 A5 CH 672887A5
Authority
CH
Switzerland
Prior art keywords
composition according
polymer
copolymer
hormone
drug substance
Prior art date
Application number
CH4022/87A
Other languages
English (en)
French (fr)
Inventor
Peter Speiser
Urs Schleuniger
Piero Orsolini
Frederic Heimgartner
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Priority to CH4022/87A priority Critical patent/CH672887A5/fr
Priority to GB8823735A priority patent/GB2211091B/en
Priority to ES8803091A priority patent/ES2009347A6/es
Priority to NL8802490A priority patent/NL8802490A/nl
Priority to IT8805224A priority patent/IT1227394B/it
Priority to PT88757A priority patent/PT88757B/pt
Priority to CA000579976A priority patent/CA1332808C/en
Priority to IE311088A priority patent/IE60475B1/en
Priority to GR880100688A priority patent/GR1000266B/el
Priority to DK571488A priority patent/DK571488A/da
Priority to FR8813487A priority patent/FR2622105B1/fr
Priority to DE3835099A priority patent/DE3835099A1/de
Priority to JP63260364A priority patent/JP2716747B2/ja
Priority to BE8801184A priority patent/BE1001687A5/fr
Publication of CH672887A5 publication Critical patent/CH672887A5/fr
Priority to US07/503,066 priority patent/US5187150A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH4022/87A 1987-10-14 1987-10-14 CH672887A5 (da)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CH4022/87A CH672887A5 (da) 1987-10-14 1987-10-14
GB8823735A GB2211091B (en) 1987-10-14 1988-10-10 Polyester-based composition for the controlled release of medicinal substances
ES8803091A ES2009347A6 (es) 1987-10-14 1988-10-11 Procedimiento para la preparacion de una composicion farmaceutica.
NL8802490A NL8802490A (nl) 1987-10-14 1988-10-11 Preparaat op basis van polyesters voor de gereguleerde afgifte van geneesmiddelen.
IT8805224A IT1227394B (it) 1987-10-14 1988-10-11 Composizione a base di poliesteri per la liberazione controllata di sostanze medicamentose.
IE311088A IE60475B1 (en) 1987-10-14 1988-10-13 Polyester-based composition for the controlled release of medicinal substances
CA000579976A CA1332808C (en) 1987-10-14 1988-10-13 Polyester-based composition for the controlled release of medicinal substances
PT88757A PT88757B (pt) 1987-10-14 1988-10-13 Processo para a preparacao de composicoes farmaceuticas com base em poliesters apropriadas para libertar de um modo controlado substancias medicamentosas
GR880100688A GR1000266B (el) 1987-10-14 1988-10-13 Μεθοδος παρασκευης μιας συνθεσης βασισμενης σε πολυεστερα για την ελεγχομενη εκλυση φαρμακευτικων ουσιων.
DK571488A DK571488A (da) 1987-10-14 1988-10-13 Polyesterpraeparat
FR8813487A FR2622105B1 (fr) 1987-10-14 1988-10-13 Composition a base de polyesters pour la liberation controlee de substances medicamenteuses
DE3835099A DE3835099A1 (de) 1987-10-14 1988-10-14 Pharmazeutische zusammensetzung
JP63260364A JP2716747B2 (ja) 1987-10-14 1988-10-14 薬剤の放出を制御するためのポリエステルを主成分とする薬剤組成物
BE8801184A BE1001687A5 (fr) 1987-10-14 1988-10-14 Composition a base de polyesters pour la liberation controlee de substances medicamenteuses.
US07/503,066 US5187150A (en) 1987-10-14 1990-03-29 Polyester-based composition for the controlled release of polypeptide medicinal substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4022/87A CH672887A5 (da) 1987-10-14 1987-10-14

Publications (1)

Publication Number Publication Date
CH672887A5 true CH672887A5 (da) 1990-01-15

Family

ID=4268357

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4022/87A CH672887A5 (da) 1987-10-14 1987-10-14

Country Status (14)

Country Link
JP (1) JP2716747B2 (da)
BE (1) BE1001687A5 (da)
CA (1) CA1332808C (da)
CH (1) CH672887A5 (da)
DE (1) DE3835099A1 (da)
DK (1) DK571488A (da)
ES (1) ES2009347A6 (da)
FR (1) FR2622105B1 (da)
GB (1) GB2211091B (da)
GR (1) GR1000266B (da)
IE (1) IE60475B1 (da)
IT (1) IT1227394B (da)
NL (1) NL8802490A (da)
PT (1) PT88757B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
CH681425A5 (da) * 1990-11-14 1993-03-31 Debio Rech Pharma Sa
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
ZA936692B (en) * 1992-09-12 1994-04-29 Dott Ltd Comp Physiologically active peptide composition
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
FR2777895A1 (fr) * 1998-04-28 1999-10-29 Debio Rech Pharma Sa Polymere sequence non-reticule,procede pour sa preparation, et ses utilisations
US20060286138A1 (en) * 2003-04-10 2006-12-21 Malshe Vinod C Novel biodegradable aliphatic polyesters and pharmaceutical compositions and applications thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
WO1978000011A1 (en) * 1977-06-07 1978-12-21 Garching Instrumente Form of implant medicament and preparation process
US4186189A (en) * 1977-09-28 1980-01-29 Ethicon, Inc. Absorbable pharmaceutical compositions based on poly(alkylene oxalates)
US4130639A (en) * 1977-09-28 1978-12-19 Ethicon, Inc. Absorbable pharmaceutical compositions based on isomorphic copolyoxalates
US4594407A (en) * 1983-09-20 1986-06-10 Allied Corporation Prosthetic devices derived from krebs-cycle dicarboxylic acids and diols
US4481353A (en) * 1983-10-07 1984-11-06 The Children's Medical Center Corporation Bioresorbable polyesters and polyester composites

Also Published As

Publication number Publication date
PT88757B (pt) 1993-01-29
DE3835099A1 (de) 1989-04-27
FR2622105B1 (fr) 1993-05-14
FR2622105A1 (fr) 1989-04-28
JPH01157920A (ja) 1989-06-21
BE1001687A5 (fr) 1990-02-06
DK571488D0 (da) 1988-10-13
ES2009347A6 (es) 1989-09-16
GR1000266B (el) 1992-05-12
IE883110L (en) 1989-04-14
IT1227394B (it) 1991-04-08
GB8823735D0 (en) 1988-11-16
IE60475B1 (en) 1994-07-13
GB2211091A (en) 1989-06-28
IT8805224A0 (it) 1988-10-11
DK571488A (da) 1989-04-15
CA1332808C (en) 1994-11-01
GB2211091B (en) 1991-02-13
NL8802490A (nl) 1989-05-01
JP2716747B2 (ja) 1998-02-18

Similar Documents

Publication Publication Date Title
US4801739A (en) Oligomeric hydroxycarboxylic acid derivatives, their production and use
BE1004486A3 (fr) Formulations a liberation prolongee de peptides solubles dans l'eau.
AU642932B2 (en) Protein microspheres and methods of using them
EP0302582B2 (en) Drug delivery system and method of making the same
KR100918092B1 (ko) 약물 함유 고분자 미립구의 제조방법 및 그 방법에 의해제조된 약물 함유 고분자 미립구
JPH06172208A (ja) 医薬物質を持続的に制御して放出できる組成物およびその製造方法
CH661206A5 (fr) Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
JP7366544B2 (ja) 非経口投与用の生分解性ポリマーミクロスフェア組成物
WO2003004024A1 (fr) Microspheres injectables a liberation prolongee de composes d'huperzine a
BE1001687A5 (fr) Composition a base de polyesters pour la liberation controlee de substances medicamenteuses.
US5187150A (en) Polyester-based composition for the controlled release of polypeptide medicinal substances
FR2571617A1 (fr) Procede pour la microencapsulation par separation de phases de substances medicamenteuses hydrosolubles
JP2013536177A (ja) ２−ヒドロキシアルキル酸から調製されたポリマーを含む組成物
BE898430A (fr) Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation.
JP3490171B2 (ja) 生体内分解性ポリマーの末端カルボキシル基におけるエステル
JPH0512328B2 (da)
JP4918808B2 (ja) 生体吸収性医薬製剤
JPS6341416A (ja) 鎮痛性ペプチド含有マイクロカプセルの製造法
JPH04208217A (ja) 徐放性製剤およびその製造方法
JP3524195B2 (ja) 徐放性製剤用基剤
CH666406A5 (de) Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
KR840001675B1 (ko) 코폴리머의 제조 방법
WO2003043605A1 (fr) Procede de preparation de microparticules sans solvant toxique, microparticules obtenues selon ce procede, utilisations et compositions pharmaceutiques
JP2539245B2 (ja) ポリ乳酸組成物
JP2001247482A (ja) ヒドロキシ酸系オリゴマー薬剤組成物

Legal Events

Date Code Title Description
PUE Assignment

Owner name: DEBIO RECHERCHE PHARMACEUTIQUE S.A.

PL Patent ceased